Profusa (NVACW) Cash from Investing Activities (2022 - 2026)
Profusa (NVACW) reported Cash from Investing Activities of $1.1 million for Q1 2026, down 82.36% on a YoY basis from $6.5 million in Q1 2025, and up 213.59% quarter-over-quarter from -$1.0 million in Q4 2025.
Profusa (NVACW) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Profusa has reported Cash from Investing Activities for 5 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 82.36% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at -$7.4 million (down 206.55% YoY), and the FY2025 full-year result was -$2.0 million, down 167.66% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $1.1 million, up from -$1.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $185.7 million in Q1 2023, with the low at -$7.5 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged $13.4 million across 5 years, with a median of $32631.5 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 206421.62% — and 2024, when it soared 699.29%.
- Profusa's Cash from Investing Activities stood at -$37.0 in 2022, then sank by 206421.62% to -$76413.0 in 2023, then soared by 699.29% to $457936.0 in 2024, then slumped by 320.12% to -$1.0 million in 2025, then surged by 213.59% to $1.1 million in 2026.
- The last three Cash from Investing Activities figures came in at $1.1 million (Q1 2026), -$1.0 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Profusa | - | - | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | 6.49 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 457,936.00 |
| Dec 31, 2024 | 457,936.00 |
| Sep 30, 2024 | -112,115.00 |
| Sep 30, 2024 | -112,115.00 |
| Jun 30, 2024 | 65,264.00 |
| Jun 30, 2024 | 65,264.00 |
| Mar 31, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | -76,413.00 |
| Dec 31, 2023 | -76,413.00 |